Hosted by: Professor David Tscharke

Abstract

This talk will review the natural history of multiple sclerosis, current understanding of the immunopathology, evolutions in therapy and how integrating translational research in to clinical practice may lead to novel therapeutic targets.

About the speaker

Dr Jennifer Massey is a consultant neurologist with a specialist interest in neuroimmunology and MS. She graduated from University of Western Australia with honours in 2009, completing neurology specialty training in 2018. In 2021 Dr Massey was awarded her PhD entitled ‘Immune reconstitution following AHSCT for MS’; investigating the clinical outcomes of patients from the St Vincent’s Clinical trial with concurrent laboratory-based immune profiling of lymphocyte reconstitution following stem cell transplant.

Dr Massey is the lead neurologist in the ongoing AHSCT for MS and other Neuroimmunological Disease trials and is a co-investigator on other MS clinical trials. She has been involved in international registry studies with EBMT and MS Base to evaluate the efficacy and toxicity of AHSCT for MS. She has been the invited speaker to multiple national and international meetings and has been grateful to present her research at numerous scientific congresses. Dr Massey is an active member of the ANZAN MS craft group, and is on the scientific board of the Trish MS Research Committee. She is the  recent recipient of an MRFF grant to explore the role of EBV in MS pathogenesis. She has become a supervisor to neurology advanced trainees at St Vincent’s and remains an active member of the Women in Neurology and International Women in MS mentoring groups.